The Expressed Genome in Cardiovascular Diseases and Stroke: Refinement, Diagnosis, and Prediction

Published: julio 31, 2017

“Omics” studies promise to deepen our understanding of cardiovascular diseases and stroke and improve our ability to diagnose, predict, and prognosticate diseases in individual patients—a key goal of precision medicine.
We now have the ability to address disease on levels that were inaccessible to us during the last century: the genome, transcriptome, epigenome, proteome, metabolome, cells, tissues, and organs.
A critical step towards the widespread use of the expressed genome in the clinic is funding of large-scale efforts to validate, replicate, and integrate the information streams arising from various -omics studies.

Supporting Materials